Table I.
Association between CLIC1 expression and clinicopathological features in patients with epithelial ovarian cancer.
| Feature | No. of cases | H-score | P-value |
|---|---|---|---|
| Age (years) | 0.692 | ||
| <55 | 139 | 177.8±21.3 | |
| ≥55 | 127 | 178.9±22.4 | |
| Tumor diameter (cm) | 0.397 | ||
| <5 | 81 | 180.1±22.3 | |
| ≥5 | 185 | 177.6±21.6 | |
| Histological type | 0.085 | ||
| Serous | 188 | 180.5±20.9 | |
| Mucus | 30 | 174.7±26.5 | |
| Endometrioid | 26 | 172.5±20.7 | |
| Clear cell | 22 | 171.7±22.6 | |
| Tumor Grade | <0.001 | ||
| Low | 28 | 162.6±31.9 | |
| Moderate | 73 | 177.6±17.8 | |
| High | 165 | 181.3±20.3 | |
| Serum CA-125 level (U/ml) | 0.979 | ||
| <35 | 78 | 178.3±20.2 | |
| ≥35 | 188 | 178.4±22.5 | |
| FIGO stage | 0.539 | ||
| Early (I–II) | 72 | 177.0±23.1 | |
| Advanced (III–IV) | 194 | 178.8±21.4 | |
| Cisplatin resistance | <0.001 | ||
| Yes | 90 | 185.0±20.1 | |
| No | 176 | 172.9±22.0 |
CA, cancer antigen; CLIC1, chloride intracellular channel 1; FIGO, International Federation of Gynecology and Obstetrics.